Asthma is a chronic disorder of the airways characterized by reversible airflow obstruction, inflammation and bronchial hyperresponsiveness. Different immune cells and molecules have been attributed to involve in pathogenesis of asthma. In the current casecontrol study, the expression of T cell Ig and mucin domain-containing molecule-3 (Tim-3) and programmed death-1 (PD-1) was studied on CD4+ T cells of patients with asthma and normal controls.
INTRODUCTION
Asthma is a chronic disorder of the airways characterized by reversible airflow obstruction, inflammation and bronchial hyperresponsiveness. Different immune cells such as T cells, B cells, mast cells, eosinophils, macrophages and neutrophils have been attributed to involve in the pathogenesis mechanisms of asthma. While the Th2 paradigm and imbalance in Th1/Th2 profile have explained many features of asthma immunopathogenesis, this mechanism does not fully characterize the etiology of asthma and then possible roles of other CD4 + T cell subsets including Th1 cells, Th17 cells and regulatory T cells have been suggested in asthma pathogenesis. [1] [2] [3] In this regard, several immunotherapeutic approaches such as blocking of Th2 cells specific transcription factor GATA binding protein 3 (GATA-3) or Th2
cytokines Interleukin-4 (IL-4) and Interleukin-13 (IL- 13) were designed to regulate the balance between Th1 and Th2 cells and inhibition of Th2 cells differentiation in patients with asthma. 4 Since these approaches were not effective in a major subset of patients, so other immune related mechanisms may involve in asthma pathogenesis.
In the last decades, a new set of immune regulatory molecules called immune checkpoint receptors have been introduced and widely studied in immune system disorders, mostly in the context of chronic inflammatory complications and cancers. 5, 6 Among different identified immune checkpoint molecules, programmed death-1 (PD-1) and T cell Ig and mucin domain-containing molecule-3 (Tim-3) are two important molecules which are expressed on a variety of immune cells and have attracted more attention in recent years. Galectin-9 was identified as the main ligand for Tim-3 and its interaction with Tim-3 was shown to induce cell death in Th1 cells. 7 These results suggested Tim-3 as an inhibitory molecule which terminates Th1 immunity. 8 Later on, the inhibitory function of Tim-3 was studied in several mouse models of autoimmune diseases and asthma. It was shown in an exacerbated experimental autoimmune encephalomyelitis (EAE) model that treatment of EAE mice with anti-Tim-3 antibody cause increasing in macrophage and aggravation of disease activity. 9 Later on it was revealed that blocking Tim-3 signaling pathway resulted in enhanced Th1 cell proliferation and cytokines secretion. 10 Other studies have also demonstrated that Tim-3 influences chronic autoimmune diseases, such as systemic lupus erythematous (SLE) and rheumatoid arthritis (RA). 11, 12 In this regard, association of Tim-3 polymorphisms with susceptibility to several autoimmune diseases has been identified. 13, 14 A study on allergic asthma patients has shown that up-regulation Tim-3 on T cells was accountable for Th1/Th2 imbalance in allergic asthma patients. Blocking of Tim-3 signaling increased Th1 cytokines response with suppression of Th2 cytokines responses. 15 In a contradictory study on mouse model using Tim-1 and Tim-3 deficient mice, it was reported that Tim-1 and Tim-3 are not essential for the induction of the type-2 response in lung allergy. 16 Similar to Tim-3, the current data supporting the role of PD-1 in Th2 polarized complications such as asthma is controversial. Following engagement with its ligands, PD-1 deliver inhibitory signals that regulate the balance between T-cell activation, tolerance and immunopathology. 17 In a study on murine model of cockroach-induced allergic asthma, it has been demonstrated that blocking of PD-1 pathway resulted in substantially increasing of Th2 cytokines, together with increasing of anti-inflammatory cytokines and IL-10. 18 In a mouse model of allergic inflammatory responses, it has been shown that PD-1-B7-H1-mediated inhibitory pathway may play a critical role in regulation of inflammatory responses and maintaining peripheral tolerance. 19 Altogether, there are limited and controversial studies about the expression and role of Tim-3 and PD-1 in asthma. In addition, most of the previous studies have focused on mouse model of asthma and there are a few reports conducted on human samples. In the present study, for the first time co-expression of Tim-3 and PD-1 were evaluated on CD4+ T cells of patients with asthma.
MATERIALS AND METHODS

Patients and Controls
A total of 37 patients with asthma attending the Tooba Clinic affiliated to Mazandaran University of Medical Sciences and 32 healthy controls were enrolled in this study. The diagnostic criteria were based on the Global Initiative for Asthma (GINA) guidelines. 20 Since, medications consumption by asthmatic patients may affect the frequency of lymphocytes and also expression of immune regulatory molecules, our asthmatic patient received inhaled corticosteroids which have less systemic effects than oral corticosteroids. But, due to the ethical limitations, we were not allowed to stop taking medications before sampling. Lung function tests and routine lab tests were performed and all patients with asthma were selected based on their abnormal spirometry results ( Table 1 ). The control group was individuals with normal pulmonary function and negative allergy tests. Written informed consent was obtained from all subjects and the study was approved by the Ethical Committee of Mazandaran University of Medical Sciences (N. 95.2633).
Peripheral Blood Mononuclear Cell Isolation
Heparinized venous blood was collected and peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation on Ficoll-Histopaque (Biosera, Nuaille, France). Isolated PBMCs were washed twice with RPMI-1640 culture medium (Biosera, Nuaille, France) supplemented with penicillin (100 IU/mL) and streptomycin (100 μg/mL) (Biosera, Nuaille, France). The viability of isolated cells was>95% as determined by trypan blue staining.
Surface Staining and Flow Cytometry Analysis
For analysis of the expression level of Tim-3 and PD-1 on CD4+ T cells, PBMCs were incubated with flourochrome-conjugated monoclonal antibodies: anti-CD4-FITC (eBioscience, San Diego, USA), anti-Tim-3-PE (eBioscience, San Diego, USA), anti-PD-1-PerCP/Cy5.5 (Biolegend San Diego, USA). Isotypematched control antibodies were also applied for background subtraction. After washing PBMCs with washing buffer (PBS 0.15M pH: 7.4 with 0.5 % BSA), 1×10 6 cells were resuspended in 100 μL of washing buffer and incubated with appropriate specific mAbs for 45 min in the dark at 4°C. Stained cells were then analyzed on a Partec PAS flow cytometer system (Partec GmBH, Munster, Germany) using the FlowMax software. For compensation analysis, the spillover amount of each flourochrome into other channels was determined and subtracted.
Cell Culture and Stimulation
For analysis of the in vitro cytokines production, PBMCs were cultured in flat-bottomed 96-well microplates (2×10 5 /well) in 200 µL RPMI-1640 medium, supplemented with penicillin (100 IU/mL), streptomycin (100 μg/mL) and 10% heat inactivated fetal bovine serum (Biosera, Nuaille, France) and incubated in 37°C with 5% CO2. For measurement of cytokine production, PBMCs were stimulated with cell stimulation cocktail containing phorbol myristate acetate (PMA) and ionomycin (eBioscience; San Diego, USA) for 18 hours.
Enzyme Linked Immunosorbent Assays (ELISA)
Total serum Immunoglobulin E (IgE) levels were measured in all samples by ELISA-based IgE detection Data are represented as mean±SEM (*) or median±interquartile ranges (**).The level of total IgE was determined by ELISA. Neutrophil and eosinophil absolute counts were calculated based on CBC-Diff results obtained from cell counter system. FEV1: forced expiratory volume in one second. FVC: forced vital capacity. kit according to the manufacturer's instruction (Euroimmun, Luebeck, Germany). The concentrations of IFN-γ and IL-4 were measured in the culture supernatants by ELISA according to the manufacturer's protocol (eBioscience, San Diego, USA). All samples were measured in duplicate. The sensitivity of IFN-γ and IL-4 ELISA kits was 4 and 2 pg/mL, respectively.
Statistical Analysis
Statistical analyses were performed with GraphPad Prism 6 and SPSS version 20 softwares. Data are expressed as the Mean±SEM or Median±interquartile ranges. T-test and non-parametric Mann-Whitney U test were used to calculate the mean difference between the groups. Pearson and spearman's rank correlation tests were used to calculate the correlation coefficients. P-values of less than 0.05 were considered significant.
RESULTS
General Characteristics of the Asthmatic Patients and Controls
The characteristics of the studied groups are summarized in Table 1 . There was no significant difference in age and gender between asthmatic patients and healthy controls. The concentration of serum total IgE and the number of eosinophils and neutrophils (Table 1) were significantly higher in asthmatic patients (p=0.03, p=0.0002 and p=0.0008, respectively). Figures 1c and 1d) .
Elevated Expression of
Evaluation of IFN-γ and IL-4 Production by PBMCs of Asthmatic Patients and Healthy Controls
PBMCs from all samples were cultured and stimulated with PMA/ionomycin. In the asthmatic group, the supernatant level of IL-4 (79 pg/mL) was significantly higher than that of the healthy control group (48 pg/mL) (Figure 2a) . But the level of IFN-γ was relatively similar in patients and controls ( Figure  2b ). As expected, the ratio of IFN-γ/ IL-4 (Th1/Th2 ratio) was significantly higher in healthy controls in comparison to asthmatic patients (Fig. 2c) which shows the polarization of the Th2 cells in asthma. A significant positive correlation was found between the IL-4 concentration and the levels of total IgE (r=0.45, p=0.0048; Figure 3a) . A significant negative correlation was also found between IFN-γ/IL-4 ratio and neutrophil absolute count in the asthma patients (r=-0.43, p=0.006; Figure 3b ). Correlation analysis between the frequency of PD-1 or Tim-3 expressing cells and concentrations of IFN-γ, IL-4 and IgE did not show any significant associations.
Frequency of Tim-3 + /PD-1 + /CD4 + T Cells and Ratio of IFNγ/IL-4 among the Clinical Subgroups of Asthmatic Patients
Following our previous observations that Tim-3 and PD-1 are upregulated on CD4 + T cells of asthmatic patients and might influence the disease progression, the frequency and cytokine production of CD4 + T cells were studied in subgroups of asthmatic patients with different clinical presentation. Patients were categorized based on the GINA guidelines; mild, moderate and severe. The concentration of total IgE and eosinophil absolute count were higher in patients with severe asthma than those of moderate and mild asthma, but the difference was not significant maybe due to the low sample size in each group (Figures 4a  and 4b ). The percentage and absolute count of Tim-3
+ T cells were higher in patients with mild asthma than those of moderate and severe asthma which was not statistically significant ( Figure 4c) . Interestingly, the IFNγ/IL-4 ratio was higher in patients with mild asthma compared to moderate asthma and then was increased in patients with severe asthma (Figure 4d ), but the difference was not significant. 
DISCUSSION
Multiple mechanisms are involved in the regulation of immune responses and deregulation of these mechanisms may lead to the development of hypersensitivity disorders including allergies and asthma. One of the mechanisms responsible for the regulation of immune response and tolerance is signaling via immune checkpoint or inhibitory receptors. Tim-3 and PD-1 are two important immune checkpoint receptors having critical roles in the maintenance of immune homeostasis which their functions in regulation of pro-inflammatory T cell response have been confirmed. Nevertheless, there are controversial findings regarding the role of Tim-3 and PD-1 in asthma. 15, 16, 21, 22 In the current study, for the first time, the co-expression of IL-4 levels in asthmatic patients together with similar production of IFN-γ by asthmatic patients and healthy controls are in concordance with the mentioned study conducting on women with normal pregnancy and abortion. 26 These observations suggest that PD-1 and Tim-3 may have no effects on the production of the IFN-γ and induce the production of IL-4. Dysregulation of Tim-3 and PD-1 expression has been reported in various autoimmune disorders like multiple sclerosis, 27 systemic lupus erythematosus 28 and rheumatoid arthritis 29 and it was shown that Tim-3 and PD-1 expression are inversely correlated with disease progression confirming their protective roles. Similarly, it seems that the higher expression of Tim-3 and PD-1 in asthmatic patients may be due to the feedback mechanisms and autoregulation of the immune responses to control the immunopathological events in this immune related disorder. Further studies are required to confirm this hypothesis and more explore the role of these immune checkpoint pathways in asthma.
Significant negative correlation between IFN-γ/IL-4 ratio and neutrophil absolute count in our asthmatic patients is consistent with the results of Nandi et al. who studied the regulatory effect of IFN-γ on neutrophils during tuberculosis infection and have shown that IFN-γ suppresses neutrophil accumulation and recruitment by inhibiting IL-17 production. 30 Therefore, our results suggest that the imbalance of IFN-γ/IL-4 ratio may be accompanied with increasing in eosinophils and neutrophils in asthmatic patients. In this study, asthmatic patients were clinically categorized into mild, moderate and severe stages based on the GINA guidelines. 20 The absolute count of 
